Insilico
PrivateLast Round
IPO Announced
Dec 30, 2025
Est. Valuation
$1.72B
Total Funding Raised
$853.21M
Company Overview
InSilico Medicine is a biotechnology and artificial intelligence company that develops an advanced AI platform and innovative drugs aimed at providing transformative solutions for cancer, fibrosis, immune disorders, central nervous system diseases, and age-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Insilico Comps
Public and private peers based on sector, stage, and business model.
Insilico Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Dec 30, 2025 | ||||
| Series E | Jun 16, 2025 | ||||
| Series E | Mar 13, 2025 | ||||
| Series E | Jan 7, 2025 | ||||
| Debt | Nov 5, 2024 | ||||
Series D Extension | Aug 10, 2022 |
Key People
Founding team and executive leadership
Insilico Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series C, Series D Extension |
| AIBasis Fund | Series C |
| Credit Suisse Asset Management | ipo |
| Temasek | ipo |
| Baidu Ventures | Series C, Series B |
| Lake Bleu Capital | Series C |
| Winter Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Unified AI framework integrates TargetPro and TargetBench for improved drug development.
- Mar 24, 2026
Partnered with ASKA Pharmaceutical Co., Ltd. for drug discovery.
Insilico Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Insilico's valuation, stock price, and market status.
